Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
This piece outlines What To Buy After Tax Loss Harvest Dividend ETF, including replacement candidates and criteria to choose wisely.
23,181 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Analysts warn of a brutal bitcoin liquidation cascade if BTC slips below $59,000, citing concentrated long leverage a...
As lithium demand climbs, Albemarle sits at a crossroads. This article breaks down the lithium rise again. does dynam...
harper beckham reportedly faces a milestone heartbreak as her brother keeps his distance during a high-profile birthd...
Jim Cramer remains wary of Salesforce as growth slows and CIOs shift budgets to less expensive software. He argues th...
Investing in nuclear energy can feel like riding a high-speed train. Oklo’s small modular reactors promise a greener ...
AI stocks surged on hype, not just earnings. Yet after robust results from taiwan semiconductor and ASML, the market ...
Could prices be rising faster than you realize because the value of what you buy is slipping? This guide explains how...
Gen Z is pushing a rebound in vinyl records and print media, shaping the market while stretching household budgets. T...
OpenAI wins a Pentagon deal to deploy its AI in classified systems as Anthropic is designated a supply chain risk by ...
As the CLARITY Act stalls in the Senate, the Trump administration escalates pressure on banks to unlock crypto bankin...
Three consumer-facing stocks — Planet Fitness, Brown-Forman, and Campbell’s — moved on earnings, tariffs, and margin ...